In vitro studies proved that knockdown of KCNMA1 inhibited cell proliferation or invasiveness in different types of cancer, such as glioblastoma, breast and prostate cancer, although this not seemed to apply to all [16,27,28]. The gene discussed is KCNMA1; the disease is glioblastoma.